Article Details
Retrieved on: 2022-02-28 01:08:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Brokerages predict that Arbutus Biopharma Co. (NASDAQ:ABUS - Get Rating) will report earnings per share (EPS) of ($0.16) for the current quarter, ...
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here